Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 181 ~ 200 of 26060, Page 10 of 1303
181. Malaria vaccine pilot launched in Malawi
Country first of three in Africa to roll out landmark vaccine / An innovation milestone, three decades in development / A model public-private partnership
04/23/2019 WHO
182. Obesity Linked with Differences in Form and Structure of the Brain
MRI shows that higher levels of body fat are associated with differences in the brain's form and structure. / Brain imaging results from more than 12,000 participants in the UK Biobank study were analyzed. / Researchers found that higher total body fat percentage increased the likelihood of changes to the brain's white matter. In men, gray matter volume was also reduced.
04/23/2019 Radiological Society of North America
183. Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staples
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
184. The Link Between Weight and Cancer Risk
Being overweight or obese puts you at greater risk for some types of cancer. Learn about the connection between weight and cancer ? and what you can do about it.
04/23/2019 American Cancer Society
185. Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls
04/23/2019 U.S. FOOD & DRUG ADMINISTRATION
186. Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine
04/22/2019 U.S. FOOD & DRUG ADMINISTRATION
187. FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Inlyta® (axitinib) as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (RCC)
Approval Based on Results of KEYNOTE-426, Where KEYTRUDA in Combination With Axitinib Reduced the Risk of Death by Nearly Half Compared to Sunitinib
04/22/2019 MERCK
188. FDA permits marketing of first medical device for treatment of ADHD
04/19/2019 U.S. FOOD & DRUG ADMINISTRATION
189. FDA approves first generic naloxone nasal spray to treat opioid overdose
Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment
04/19/2019 U.S. FOOD & DRUG ADMINISTRATION
190. WHO releases first guideline on digital health interventions
Digital health interventions are not sufficient on their own /
04/17/2019 WHO
191. Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease
Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease.
04/17/2019 Medtronic
192. Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies
New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies
04/17/2019 Medtronic
193. Abbott Reports First-Quarter 2019 Results
ABBOTT PARK, Ill., April 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2019.
04/17/2019 Abbott
194. FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to remove all devices from the market
04/16/2019 U.S. FOOD & DRUG ADMINISTRATION
195. Radiology Publishes Roadmap for AI in Medical Imaging
In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and The Academy for Radiology and Biomedical Imaging Research (The Academy). The organizers aimed to foster collaboration in applications for diagnostic medical imaging, identify knowledge gaps and develop a roadmap to prioritize research needs. The group''s research roadmap was published today as a special report in the journal Radiology.
04/16/2019 Radiological Society of North America
196. FDA Approves First Targeted Therapy for Bladder Cancer
The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
04/16/2019 American Cancer Society
197. FDA Statement from Deputy Commissioner for Food Policy and Response Frank Yiannas on new steps to protect consumers from unlawful ingredients in dietary supplements
04/16/2019 U.S. FOOD & DRUG ADMINISTRATION
198. FDA Warns of Cancer Risk in a Type of Uterine Fibroid Surgery
The US Food and Drug Administration (FDA) is warning women and doctors about the risks of a certain technique used in surgery for uterine fibroids.
04/15/2019 American Cancer Society
199. At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices
WHO to continue to facilitate countries' information-sharing to improve transparency on prices
04/13/2019 WHO
200. Results of Phase 3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019
ASPECT-NP Clinical Trial Results Demonstrated Non-Inferiority of ZERBAXA to Meropenem for Treating Ventilated Nosocomial Pneumonia in Primary and Key Secondary Endpoints
04/13/2019 MERCK
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱